Phase II Trial of Combination Pemetrexed (Alimta) and Carboplatin (Paraplatin) in Platinum Sensitive Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Carcinoma
Phase of Trial: Phase II
Latest Information Update: 20 Feb 2017
At a glance
- Drugs Pemetrexed (Primary) ; Carboplatin
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 11 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 08 Jul 2011 Planned end date changed from 1 Apr 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 06 Nov 2009 New trial record